Therapeutic Drugs and Devices for Tackling Ocular Hypertension and Glaucoma, and Need for Neuroprotection and Cytoprotective Therapies
Damage to the optic nerve and the death of associated retinal ganglion cells (RGCs) by elevated intraocular pressure (IOP), also known as glaucoma, is responsible for visual impairment and blindness in millions of people worldwide. The ocular hypertension (OHT) and the deleterious mechanical forces...
Main Author: | Najam A. Sharif |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.729249/full |
Similar Items
-
Neuroprotection in glaucoma
by: Vasudevan Sushil, et al.
Published: (2011-12-01) -
Ocular hypotensive effect of fermented Pentaclethra macrophylla seeds in experimentally-induced glaucoma
by: Ikechukwu Jacob Okoro, et al.
Published: (2023-12-01) -
Glucocorticoid-Induced Ocular Hypertension and Glaucoma
by: Harvey DH, et al.
Published: (2024-02-01) -
Role of interleukin-6 in the pathogenesis of glaucoma
by: Pan Liu, et al.
Published: (2018-10-01) -
Elevated Levels of Growth/Differentiation Factor-15 in the Aqueous Humor and Serum of Glaucoma Patients
by: Rupalatha Maddala, et al.
Published: (2022-01-01)